A Markovian model for comparing incidences of side effects

Area of Science:

• Biostatistics
• Clinical Trial Methodology
• Epidemiology

Background:

• Clinical trials frequently involve repeated observations of binary outcomes, such as side effect occurrences.
• Accurate comparison of side effect incidence rates is crucial for drug safety and efficacy assessment.
• Missing data, often due to patient withdrawal, presents a significant challenge in analyzing longitudinal trial data.

Purpose of the Study:

• To develop and present a likelihood-based statistical method for comparing side effect incidence rates in clinical trials.
• To address the challenge of missing data arising from premature withdrawals in longitudinal studies.
• To provide a robust analytical framework for side effect surveillance during clinical investigations.

Main Methods:

• A likelihood-based approach is employed for statistical inference.
• The core methodology assumes a first-order Markov chain model for the sequence of binary responses (side effect occurrence).
• The proposed method explicitly incorporates mechanisms to handle missing data points resulting from patient dropouts.

Main Results:

• The developed method provides a statistically sound basis for comparing side effect incidence rates.
• The technique demonstrates efficacy in handling missing data, preserving analytical integrity.
• Illustrative examples using both real clinical data and simulated data confirm the method's practical applicability and validity.

Conclusions:

• The presented likelihood-based Markov chain method offers an effective solution for comparing side effect rates in longitudinal clinical trials.
• This approach enhances the analysis of clinical trial data by appropriately managing missing observations.
• The technique facilitates more reliable assessments of drug-related side effects, contributing to patient safety.